Osiris Therapeutics, Inc. Receives ISO Certification

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), today announced that it has received International Organization for Standardization (ISO) 13485:2003 Certification, an internationally recognized quality standard designed to ensure that medical device manufacturers have the required quality systems in place. This certificate of conformance applies to Osiris Therapeutics’ facility in Columbia, Maryland.
MORE ON THIS TOPIC